CTSI Translational Pilot Studies Program awards 13 new grants for 2021-22

picture collage.

Pictured, in alphabetical order, the principal investigators and co-investigators for projects awarded 2021-22 CTSI pilot studies funding.

Published January 20, 2021

Print
Brahm Segal.
“The pilot studies grant awardees for 2021-22 include projects that address significant translational research questions.”

The University at Buffalo’s Clinical and Translational Science Institute (CTSI) has awarded 13 new grants to support innovative translational research projects in Western New York. The CTSI Translational Pilot Studies Program provides seed money to investigators to assist them in developing promising new technologies and therapeutics from the conceptual stage to clinical studies.

“The pilot studies grant awardees for 2021-22 include projects that address significant translational research questions,” says CTSI Pilot Studies Program Director Brahm Segal, MD, Chair, Department of Internal Medicine, Chief, Division of Infectious Diseases, and Professor of Oncology, Roswell Park Comprehensive Cancer Center. “In addition to developing new methods and technologies, these projects will foster cross-disciplinary collaborations and mentoring relationships.”

Recipients of 2021-22 Translational Pilot Studies Program awards are:

Development of a Smartphone-Based Family Planning Intervention for African Refugee Women With Low Literacy

Principal Investigator: Kafuli Agbemenu, PhD, MPH, RN, CTN-A, School of Nursing

Co-Investigators: Sonya Borrero, MD, MS, Director, Center For Women’s Health Research and Innovation, University of Pittsburgh; Gretchen Ely, PhD, School of Social Work; Helen (Hua) Wang, PhD, Department of Communication, College of Arts and Sciences; Sondra Dawes, BS, Jericho Road Community Health Center — Priscilla Project; Francine Rwanika, Jericho Road Community Health Center — Priscilla Project

Role of Pioglitazone Therapy in Management of Insulin Resistance Associated With Androgen Deprivation Therapy (ADT) in Patients With Prostate Cancer

Principal Investigator: Paresh Dandona, MD, PhD, Jacobs School of Medicine and Biomedical Sciences

Co-Investigators: Gurkamal Chatta, MD, Roswell Park Comprehensive Cancer Center; Husam Ghanim, PhD, Jacobs School; Manav Batra, MD, Jacobs School; Itivrita Goyal, MD, University of Oklahoma; Manu Raj Pandey, MBBS, Roswell Park; Roberto Pili, MD, Jacobs School

A Pilot Placebo-Controlled Randomized Double-Blind Trial of Melatonin in Outpatients With COVID-19 Infection

Principal Investigator: Margarita L. Dubocovich, PhD, Jacobs School of Medicine and Biomedical Sciences

Co-Investigators: Jessica L. Reynolds, PhD, Jacobs School; Sanjay Sethi, MD, Jacobs School; Gregory E. Wilding, PhD, School of Public Health and Health Professions; Alberto Monegro, MD, Jacobs School; Rajesh Kunadharaju, MD, Jacobs School; Daniel Zinkovsky, PharmD, Jacobs School

Examining the Feasibility of a Community Health Worker Program Embedded in Western New York Community Pharmacies to Address Social Determinants of Health

Principal Investigators: David M. Jacobs, PharmD, PhD, School of Pharmacy and Pharmaceutical Sciences; Christopher J. Daly, PharmD, MBA, School of Pharmacy and Pharmaceutical Sciences

Established Investigator: Ekaterina Noyes, PhD, School of Public Health and Health Professions

Functional MRI Improves Clinical Outcome Prediction After Acute Stroke

Principal Investigator: Amit Kandel, MD, MBA, Jacobs School of Medicine and Biomedical Sciences

Co-Investigators: Michael G. Dwyer, PhD, Jacobs School; Adnan Siddiqui, MD, PhD, Jacobs School; Robert Zivadinov, MD, PhD, Jacobs School

Classifying Sports-Related Concussions by Symptom Profiles

Principal Investigator: Jeffrey C. Miecznikowski, PhD, School of Public Health and Health Professions

Co-Investigators: Mohammad Nadir Haider, MD, Jacobs School of Medicine and Biomedical Sciences; Barry Willer, PhD, Jacobs School; John J. Leddy, MD, Jacobs School

Integration of Cancer Survivorship Into the Rural United States (ICaRUS)

Principal Investigator: Ekaterina Noyes, PhD, School of Public Health and Health Professions

Co-Investigators: Gregory E. Wilding, PhD, School of Public Health and Health Professions; Kathryn Glaser, PhD, Roswell Park Comprehensive Cancer Center

Role of NANOG in Improving Function After Peripheral Nerve Injury

Principal Investigator: Kirkwood E. Personius, PT, PhD, School of Public Health and Health Professions

Co-Investigators: Stelios Andreadis, PhD, School of Engineering and Applied Sciences; Susan B. Udin, PhD, Jacobs School of Medicine and Biomedical Sciences

Home-Based Dual-Task Exercise for Older Adults With MCI

Principal Investigator: Nikhil Satchidanand, PhD, Jacobs School of Medicine and Biomedical Sciences

Co-Investigator: Bruce Troen, MD, Jacobs School

A Framework for Fusing Histopathology and Genomics Features for Diabetes Diagnosis and Prognosis

Principal Investigator: Pinaki Sarder, PhD, Jacobs School of Medicine and Biomedical Sciences

Co-Investigators: John E. Tomaszewski, MD, Jacobs School; Norma J. Nowak, PhD, Jacobs School; Rabi Yacoub, MD, Jacobs School

Immune Priming Strategy to Improve Delivery and Efficacy of Immunotherapeutics in Pancreatic Cancer

Principal Investigator: Robert M. Straubinger, PhD, School of Pharmacy and Pharmaceutical Sciences

Co-Investigators: Tista Roy Chaudhuri, PhD, School of Pharmacy and Pharmaceutical Sciences; Michael Feigin, PhD, Roswell Park Comprehensive Cancer Center; Scott Abrams, PhD, Roswell Park; Donald E. Mager, PhD, School of Pharmacy and Pharmaceutical Sciences

GsMTx4-D as an Exon-Skipping Gene Therapy Adjuvant in Duchenne Muscular Dystrophy

Principal Investigator: Thomas Suchyna, PhD, Jacobs School of Medicine and Biomedical Sciences

Co-Investigators: Carrie Miceli, PhD, UCLA School of Medicine; Christopher Ward, PhD, University of Maryland School of Medicine

Targeting Coronary Microvascular Dysfunction to Treat Heart Failure with Preserved Ejection Fraction

Principal Investigator: Brian Weil, PhD, Jacobs School of Medicine and Biomedical Sciences

Co-Investigators: B. Rita Alevriadou, PhD, Jacobs School; Thomas Suchyna, PhD, Jacobs School

Funding for the CTSI Translational Science Pilot Studies Program is provided by: UB’s Office of the Provost, Office of the Vice President for Research and Economic Development, and Office of the Vice President for Health Sciences; Roswell Park Comprehensive Cancer Center; and the deans of UB’s Jacobs School of Medicine and Biomedical Sciences, School of Dental Medicine, School of Pharmacy and Pharmaceutical Sciences, School of Engineering and Applied Sciences, School of Public Health and Health Professions, and School of Nursing.